Molecular Diagnostics Devices and Equipment Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth

Executive Summary

This report describes and explains the global molecular diagnostics devices and equipment market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.

Molecular diagnostics devices are used to diagnose infectious diseases and perform screening by detecting specific sequences in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) at a molecular level. It helps doctors to prescribe more accurate therapeutic interventions in the early stages of a disease. Molecular diagnostics devices and equipment are segmented by product into instruments, reagents, consumables and software. These devices and equipment are used in diagnostic laboratories, hospitals and by other end-users such as nursing homes, blood banks and clinical point of care settings.

The global molecular diagnostics devices and equipment market reached a value of nearly $18,074.7 million in 2020, having increased at a compound annual growth rate (CAGR) of 26.0% since 2015. The market is expected to grow from $18,074.7 million in 2020 to $19,011.3 million in 2025 at a rate of 1.0%. The market is then expected to grow at a CAGR of 6.9% from 2025 and reach $26,508.0 million in 2030.

Growth in the historic period resulted from rise in funding, increase in healthcare expenditure, economic growth in emerging markets, rapid technological advances, emergence of novel pathogenic infestations, and rapid growth in geriatric population. The market was restrained by political uncertainties, regulatory challenges, reduction in free trade, and low healthcare reimbursements.

Going forward rapid rise in various bacterial and viral epidemics, aging population, increase in healthcare access, rising prevalence of chronic diseases and increasing demand for molecular diagnostic devices and equipment due to COVID-19 will drive the growth. Factors that could hinder the growth of the molecular diagnostics devices and equipment market in the future include lack of well-defined regulatory framework, ethical concerns related to genomic study, high costs of tests and lack of skilled/trained molecular biologists.

The molecular diagnostics devices and equipment market is segmented by product into instruments, reagents and consumables and software. The reagents and consumables market was the largest segment of the molecular diagnostics devices and equipment market segmented by product, accounting for 60.6% of the total in 2020. Going forward, the software segment is expected to be the fastest growing segment in the molecular diagnostics devices and equipment market segmented by product, at a CAGR of 1.3% during 2020-2025.

The molecular diagnostics devices and equipment market is segmented by end-user into diagnostic laboratories, hospitals and others. The diagnostic laboratories market was the largest segment of the molecular diagnostics devices and equipment market segmented by end-user, accounting for 52.5% of the total in 2020. Going forward, the diagnostic laboratories segment is expected to be the fastest growing segment in the molecular diagnostics devices and equipment market segmented by end-user, at a CAGR of 1.1% during 2020-2025.

The molecular diagnostics devices and equipment market is segmented by technology into DNA (deoxyribonucleic acid) sequencing, polymerase chain reaction, isothermal nucleic acid amplification technology, transcription mediated amplification (TMA), in situ hybridization, microarrays, mass spectrometry, others (southern blotting, northern blotting, electrophoresis). The DNA (deoxyribonucleic acid) sequencing market was the largest segment of the molecular diagnostics devices and equipment market segmented by technology, accounting for 29.0% of the total in 2020. Going forward, the transcription mediated amplification (TMA) segment is expected to be the fastest growing segment in the molecular diagnostics devices and equipment market segmented by technology, at a CAGR of 1.2% during 2020-2025.

The molecular diagnostics devices and equipment market is segmented by application into cancer, pharmacogenomics, genetic testing, infectious disease, prenatal, neurological disease, and cardiovascular disease. The genetic testing market was the largest segment of the molecular diagnostics devices and equipment market segmented by application, accounting for 41.8% of the total in 2020. Going forward, the infectious disease segment is expected to be the fastest growing segment in the molecular diagnostics devices and equipment market segmented by application, at a CAGR of 1.3% during 2020-2025.

North America was the largest region in the global molecular diagnostics devices and equipment market, accounting for 34.5% of the total in 2020. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the molecular diagnostics devices and equipment market will be South America and Eastern Europe, where growth will be at CAGRs of 4.1% and 3.8% respectively. These will be followed by Africa and Middle East where the markets are expected to grow at CAGRs of 3.7% and 3.1% respectively.

The molecular diagnostics devices and equipment market is highly concentrated, with a small number of large players dominating the market. The key players in the market are focusing on expanding their operational and business presence in the molecular diagnostics market through development of innovative technologies and strategic acquisition of emerging companies in the industry. The top 10 companies in the market occupied 70.30% of market share in the global molecular diagnostics devices and equipment market. Major players in the market include F. Hoffmann-La Roche Ltd, Danaher Corporation, QIAGEN N. V., Hologic, Biomérieux, Siemens Healthineers AG, Becton, Dickinson & Co, Abbott Laboratories, Grifols, S. A., and Sysmex Corporation.

The top opportunities in the molecular diagnostics devices and equipment market segmented by product will arise in the reagents and consumables segment, which will gain $610.6 million of global annual sales by 2025. The top opportunities in the molecular diagnostics devices and equipment market segmented by end-user will arise in the diagnostic laboratories segment, which will gain $530.6 million of global annual sales by 2025. The top opportunities in the molecular diagnostics devices and equipment market segmented by technology will arise in the DNA (deoxyribonucleic acid) sequencing segment, which will gain $304.7 million of global annual sales by 2025. The top opportunities in the molecular diagnostics devices and equipment market segmented by application will arise in the genetic testing segment, which will gain $345.8 million of global annual sales by 2025. The molecular diagnostics devices and equipment market size will gain the most in the Japan at $171.3 million.

Market-trend-based strategies for the molecular diagnostics devices and equipment market include automation in the field of molecular diagnostics, use of artificial intelligence, increased demand for molecular diagnostic devices in studying rare diseases, growing adoption of big data, next generation sequencing for newborn screening, and point-of-care molecular diagnostics (POC MDx).

Player-adopted strategies in the molecular diagnostics devices and equipment market include development of advanced and innovative laboratory solutions, acquisition of emerging and established companies in molecular diagnostics, and of innovative technologies.

To take advantage of these opportunities, the publisher recommends the molecular diagnostics devices and equipment manufacturing companies to focus on the use of automation and artificial intelligence (AI) to enhance productivity and consistency of the whole diagnostic process, expanding activities to emerging markets to gain market share, offer competitively priced products to attract the users, use online portals, business websites and listing websites and participate in trade shows and events to reach targeted audience, among other strategies.

Amidst the unprecedented outbreak of corona virus, governments across the world are advising people to stay indoors and practice social distancing, to reduce the spread of the pandemic. Its impact has been seen on the global molecular diagnostics devices and equipment market. The pandemic has accelerated the adoption of molecular diagnostics devices and equipment in the healthcare industry, highlighting the power of sequencing-based diagnostic testing in global efforts to combat the spread of the infectious diseases, and its importance in supporting recovery efforts.

Companies Mentioned

A selection of companies mentioned in this report includes:

• F. Hoffmann-La Roche Ltd
• QIAGEN N.V.
• Hologic
• Abbott Laboratories
• Danaher Corporation
• Biomérieux
• Becton, Dickinson & Co
• Siemens Healthineers AG
• Grifols, S.A.
• Sysmex Corporation
• Biocartis
• Bio-Techne India Private Limited
• Bio-Rad laboratories India Pvt.Ltd
• Cleaver Scientific
• QuantuMDx
• Interlabservis
• GeneMe
• TestLine Clinical Diagnostics s.r.o.
• Johnson & Johnson
• Illumina, Inc.
• Novartis AG
• Cepheid, Inc.
• Ortho Clinical Diagnostics, Inc
• Beckman Coulter Inc.
• Thermo Fisher Scientific
• Grifols International S.A.

Methodology